Mortgage Blog

Marinus Pharmaceuticals expects to reel in $60M from stock, warrants sale

The proceeds will be used to further commercialization efforts for the company's first and only FDA-approved product.

Previous Levine Children’s pediatric hospitalists extend care to communities across the North Carolina region
Next Meet the new dean of Wake Forest University School of Medicine and chief science officer of Atrium Health

Related Posts

Suggested Posts